Spontaneous Iliopsoas Muscle Hemorrhage Secondary to Ibrutinib (Imbruvica; Pharmacyclics): Brief Report

Ibrutinib (Imbruvica; Pharmacyclics) is the first Food and Drug Administration–approved inhibitor of Burton’s tyrosine kinase (BTK). Attenuation of BTK signaling ultimately leads to inhibition of B-cell proliferation and apoptosis. After a series of clinical trials, the Food and Drug Administration...

Descripción completa

Detalles Bibliográficos
Autores principales: Sarcon, Anna, Botta, Gregory P., Patel, Nikunj, Saven, Alan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2016
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4871198/
https://www.ncbi.nlm.nih.gov/pubmed/27231694
http://dx.doi.org/10.1177/2324709616648457

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4871198/
https://www.ncbi.nlm.nih.gov/pubmed/27231694
http://dx.doi.org/10.1177/2324709616648457

Ejemplares similares